EA200100534A1 - Производные 2,4-дизамещенного триазина - Google Patents

Производные 2,4-дизамещенного триазина

Info

Publication number
EA200100534A1
EA200100534A1 EA200100534A EA200100534A EA200100534A1 EA 200100534 A1 EA200100534 A1 EA 200100534A1 EA 200100534 A EA200100534 A EA 200100534A EA 200100534 A EA200100534 A EA 200100534A EA 200100534 A1 EA200100534 A1 EA 200100534A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alkyl
optionally substituted
alkyloxycarbonyl
nhc
pyridazinyl
Prior art date
Application number
EA200100534A
Other languages
English (en)
Other versions
EA004501B1 (ru
Inventor
Барт Де Корт
Марк Рене Де Жонж
Ян Херес
Поль Адриан Ян Жанссен
Роберт В. Каваш
Люсьен Мария Хенрикус Койманс
Майкл Джозеф Кукла
Дональд Вилльям Лудовики
Кун Жанн Альфонс Ван Акен
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA200100534A1 publication Critical patent/EA200100534A1/ru
Publication of EA004501B1 publication Critical patent/EA004501B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/42—One nitrogen atom
    • C07D251/46—One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y10S977/775—Nanosized powder or flake, e.g. nanosized catalyst
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Данное изобретение относится к использованию соединений формулы (I)их N-оксидов, фармацевтически приемлемых аддитивных солей, четвертичных аминов и стереохимически изомерных форм, в которой -a=a-a=a- образует фенил, пиридинил, пиримидинил, пиридазинил или пиразинил с присоединенной винильной группой; n равно 0-4 и, когда возможно, 5; Rпредставляет водород, арил, формил, Cалкилкарбонил, Cалкил, Cалкилоксикарбонил или замещенный Cалкил; каждый Rнезависимо представляет гидрокси, галоген, необязательно замещенный Cалкил, Cалкенил или Cалкинил, Cциклоалкил, Cалкилокси, Cалкилоксикарбонил, карбоксил, циано, нитро, амино, моно- или ди(Cалкил)амино, полигалогенметил, полигалогенметилокси, полигалогенметилтио, -S(=O)R, -NH-S(=O)R, -C(=O)R, -NHC(=O)H, -C(=O)NHNH, -NHC(=O)R, -C(=NH)Rили 5-членное гетероциклическое кольцо; р равно 1 или 2; L представляет необязательно замещенный Cалкил, Cалкенил, Cалкинил или Cциклоалкил; или L представляет -X-R, где Rпредставляет необязательно замещенный фенил, пиридинил, пиримидинил, пиразинил или пиридазинил; X представляет -NR-, -NH-NH-, -N=N-, -O-, -C(=O)-, -CHOH-, -S-, -S(=O)- или -S(=O)-; арил представляет необязательно замещенный фенил; для изготовления лекарственных средств для лечения пациентов, страдающих от инфекции ВИЧ (Вирус Иммунодефицита Человека).Отчет о международном поиске был опубликован 2000.09.21.
EA200100534A 1998-11-10 1999-11-04 Производные 2,4-дизамещенного триазина EA004501B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10779998P 1998-11-10 1998-11-10
EP99203128 1999-09-24
PCT/EP1999/008688 WO2000027828A2 (en) 1998-11-10 1999-11-04 2,4-disubstituted triazine derivatives with anti hiv activity

Publications (2)

Publication Number Publication Date
EA200100534A1 true EA200100534A1 (ru) 2001-10-22
EA004501B1 EA004501B1 (ru) 2004-04-29

Family

ID=26153374

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100534A EA004501B1 (ru) 1998-11-10 1999-11-04 Производные 2,4-дизамещенного триазина

Country Status (35)

Country Link
US (2) US6638932B1 (ru)
EP (1) EP1129079B1 (ru)
JP (1) JP2002529457A (ru)
KR (1) KR100620402B1 (ru)
CN (1) CN1207290C (ru)
AP (1) AP1636A (ru)
AR (1) AR021137A1 (ru)
AT (1) ATE315031T1 (ru)
AU (1) AU764472B2 (ru)
BG (1) BG65160B1 (ru)
BR (1) BR9915176A (ru)
CA (1) CA2351203C (ru)
CY (1) CY1105596T1 (ru)
CZ (1) CZ20011532A3 (ru)
DE (1) DE69929354T2 (ru)
DK (1) DK1129079T3 (ru)
EA (1) EA004501B1 (ru)
EE (1) EE200100253A (ru)
ES (1) ES2257081T3 (ru)
HK (1) HK1038232A1 (ru)
HR (1) HRP20010310A2 (ru)
HU (1) HUP0104395A3 (ru)
ID (1) ID28545A (ru)
IL (2) IL143024A0 (ru)
MY (1) MY126781A (ru)
NO (1) NO319788B1 (ru)
NZ (1) NZ510919A (ru)
OA (1) OA11675A (ru)
PL (1) PL196523B1 (ru)
PT (1) PT1129079E (ru)
SI (1) SI1129079T1 (ru)
SK (1) SK6022001A3 (ru)
TR (1) TR200101319T2 (ru)
TW (1) TW541305B (ru)
WO (1) WO2000027828A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129079B1 (en) * 1998-11-10 2006-01-04 Janssen Pharmaceutica N.V. 2,4-disubstituded triazine derivatives with anti hiv activity
DE19945982A1 (de) 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US7276510B2 (en) 2000-05-08 2007-10-02 Janssen Pharmaceutica, Inc. HIV replication inhibitors
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
CA2513123C (en) * 2003-02-07 2013-04-23 Janssen Pharmaceutica N.V. Hiv inhibiting 1,2,4-triazines
CN101035773B (zh) 2004-08-10 2012-06-06 詹森药业有限公司 抑制hiv的1,2,4-三嗪-6-酮衍生物
GB201204756D0 (en) * 2012-03-19 2012-05-02 Lewi Paulus J Triazines with suitable spacers for treatment and/or prevention of HIV infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4927592B1 (ru) 1970-05-13 1974-07-18
BE754242A (fr) * 1970-07-15 1971-02-01 Geigy Ag J R Diamino-s-triazines et dinitro-s-triazines
US4650867A (en) 1985-03-26 1987-03-17 Ciba-Geigy Corporation Process for the preparation of 2,4,6-tris(aminophenylamino)triazines
JPH02308248A (ja) * 1989-05-24 1990-12-21 Fuji Photo Film Co Ltd アミノピリミジン系色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料
AU692484B2 (en) 1993-10-12 1998-06-11 Du Pont Pharmaceuticals Company 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
US5691364A (en) * 1995-03-10 1997-11-25 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
NO311614B1 (no) * 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
NZ506417A (en) * 1998-02-17 2003-05-30 Tularik Inc Anti-viral pyrimidine derivatives
EP1129079B1 (en) * 1998-11-10 2006-01-04 Janssen Pharmaceutica N.V. 2,4-disubstituded triazine derivatives with anti hiv activity

Also Published As

Publication number Publication date
CA2351203A1 (en) 2000-05-18
BG105419A (en) 2001-11-30
CN1207290C (zh) 2005-06-22
CA2351203C (en) 2009-03-24
BG65160B1 (bg) 2007-04-30
TW541305B (en) 2003-07-11
US6638932B1 (en) 2003-10-28
SI1129079T1 (sl) 2006-06-30
DK1129079T3 (da) 2006-05-15
IL143024A (en) 2006-06-11
NO319788B1 (no) 2005-09-12
CY1105596T1 (el) 2010-07-28
ID28545A (id) 2001-05-31
HK1038232A1 (en) 2002-03-08
IL143024A0 (en) 2002-04-21
ATE315031T1 (de) 2006-02-15
PL348145A1 (en) 2002-05-06
WO2000027828A3 (en) 2000-09-21
CZ20011532A3 (cs) 2001-10-17
AU1046200A (en) 2000-05-29
EA004501B1 (ru) 2004-04-29
DE69929354T2 (de) 2006-09-14
BR9915176A (pt) 2001-08-14
EP1129079B1 (en) 2006-01-04
HUP0104395A2 (hu) 2002-04-29
EE200100253A (et) 2002-12-16
PL196523B1 (pl) 2008-01-31
HUP0104395A3 (en) 2003-02-28
SK6022001A3 (en) 2002-01-07
EP1129079A2 (en) 2001-09-05
NO20011934L (no) 2001-04-19
NZ510919A (en) 2003-11-28
KR100620402B1 (ko) 2006-09-13
DE69929354D1 (de) 2006-03-30
HRP20010310A2 (en) 2002-06-30
US20050277641A1 (en) 2005-12-15
NO20011934D0 (no) 2001-04-19
AU764472B2 (en) 2003-08-21
MY126781A (en) 2006-10-31
PT1129079E (pt) 2006-05-31
AR021137A1 (es) 2002-06-12
JP2002529457A (ja) 2002-09-10
CN1325387A (zh) 2001-12-05
WO2000027828A2 (en) 2000-05-18
AP1636A (en) 2006-07-17
KR20010075234A (ko) 2001-08-09
ES2257081T3 (es) 2006-07-16
US7015221B2 (en) 2006-03-21
TR200101319T2 (tr) 2001-10-22
OA11675A (en) 2005-01-12

Similar Documents

Publication Publication Date Title
EA200100536A1 (ru) Пиримидины, ингибирующие репликацию вич
TR200002760T2 (tr) HIV engelleyici pirimidin türevleri
EA200400304A1 (ru) Производные пиримидина, ингибирующие вич
TR200002761T2 (tr) HIV enfeksiyonlarının tedavisi için üç-ikameli 1,3,5-triazin türevleri.
MY141597A (en) 2,4-disubstituted thiazolyl derivatives
ATE181080T1 (de) Hiv-proteaseinhibitoren
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
DE69835430D1 (de) Sulfonamidderivate, ihre herstellung und verwendung
ATE139233T1 (de) Annelierte thiophen-derivate, ihre herstellung und verwendung
JO2321B1 (en) 4-phenyl-pyridine derivatives
CY1105596T1 (el) Παραγωγα 2,4-δισυποκατεστημενης τριαζινης με δραση κατα του hiv
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
YU39503A (sh) Derivati pirimidina
ATE500231T1 (de) Hiv hemmende pyrimidin derivate
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU